Within multiple in vitro experimental systems, CELF1 protein expression is both necessary and sufficient to drive EMT, and CELF1 loss-of-function in mesenchymal/de-differentiated breast cancer cell lines drives them back to a more epithelial/differentiated state. This evidence concerns the gene CELF1 and breast carcinoma.